The CodeBreak 300 Trial in KRAS G12C-mutated mCRC - report from ESMO2023

from Medical Digest & Congress Report · host Medical Congress News

Professor Clara Montagut Viladot discusses the primary results from the phase 3 CodeBreak 300 trial of sotorasib plus panitumumab in KRAS G12C–mutated metastatic colorectal cancer. Video: https://medicaldigest.org/scientific-contents/interview:codebreak-300-trial-kras-g12c-mutated-mcrc

Episode metadata supplied by the publisher feed · Published Nov 1, 2023

Embed this episode

Attribution link and audio player

NOW PLAYING

The CodeBreak 300 Trial in KRAS G12C-mutated mCRC - report from ESMO2023

0:00 2:24

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Medical Digest & Congress Report?

This episode is 2 minutes long.

When was this Medical Digest & Congress Report episode published?

This episode was published on November 1, 2023.

Can I download this Medical Digest & Congress Report episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!